Epigenomics Balance Sheet Health
Financial Health criteria checks 4/6
Epigenomics has a total shareholder equity of €1.9M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €4.2M and €2.3M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
Interest coverage ratio | n/a |
Cash | €3.58m |
Equity | €1.91m |
Total liabilities | €2.31m |
Total assets | €4.22m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0QXH's short term assets (€4.2M) exceed its short term liabilities (€2.2M).
Long Term Liabilities: 0QXH's short term assets (€4.2M) exceed its long term liabilities (€158.0K).
Debt to Equity History and Analysis
Debt Level: 0QXH is debt free.
Reducing Debt: 0QXH has no debt compared to 5 years ago when its debt to equity ratio was 135.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0QXH has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0QXH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.